• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Qualigen Therapeutics News

    0,311 $ +2,24% +0,0068 $
    In : 0,2909 € | 26.04.24 21:22:17 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3D1RX
    ISIN: US74754R2022
    US-Symbol: QLGN
    Typ: Aktie

    Qualigen Therapeutics News

    30.11.21 - PR Newswire
    Thinking about buying stock in NLS Pharmaceutics, Petros Pharmaceuticals, Palatin Technologies, TG Therapeutics, or Qualigen Therapeutics?
    Thinking about buying stock in NLS Pharmaceutics, Petros Pharmaceuticals, Palatin Technologies, TG Therapeutics, or Qualigen Therapeutics? PR Newswire
    23.11.21 - PR Newswire
    Thinking about buying stock in Qualigen Therapeutics, Lucid Group, Micron Technology, TAL Education, or Occidental Petroleum?
    Thinking about buying stock in Qualigen Therapeutics, Lucid Group, Micron Technology, TAL Education, or Occidental Petroleum? PR Newswire
    01.03.21 - GlobeNewswire
    Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
    CARLSBAD, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) , a biotechnology company focused on developing novel therapeutics for ...
    26.01.21 - PR Newswire
    Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China
    Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China PR Newswire
    22.12.20 - PR Newswire
    Qualigen Therapeutics Issues CEO Letter to Stockholders with 2021 Outlook
    Qualigen Therapeutics Issues CEO Letter to Stockholders with 2021 Outlook PR Newswire
    18.12.20 - PR Newswire
    Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
    Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering PR Newswire
    16.12.20 - PR Newswire
    Qualigen Therapeutics, Inc. Announces $12 Million Registered Direct Offering
    Qualigen Therapeutics, Inc. Announces $12 Million Registered Direct Offering PR Newswire
    15.12.20 - PR Newswire
    Qualigen Therapeutics Announces Issuance of U.S. Patent for Expanded Applications of ALAN Anticancer Platform Technology
    Qualigen Therapeutics Announces Issuance of U.S. Patent for Expanded Applications of ALAN Anticancer Platform Technology PR Newswire
    08.12.20 - PR Newswire
    Qualigen Therapeutics Announces Board Member Amy Broidrick as EVP, Chief Strategy Officer and Names Sidney Emery, Jr. to its Board
    Qualigen Therapeutics Announces Board Member Amy Broidrick as EVP, Chief Strategy Officer and Names Sidney Emery, Jr. to its Board - Amy Broidrick, a strategic and marketing ...
    02.12.20 - PR Newswire
    Qualigen Therapeutics Completes Recertification of Existing AS1411 Drug Supply for Use in Upcoming Clinical Trials
    Qualigen Therapeutics Completes Recertification of Existing AS1411 Drug Supply for Use in Upcoming Clinical Trials PR Newswire
    13.11.20 - PR Newswire
    Qualigen Therapeutics Issues CEO Letter to Stockholders, Reports on Significant Progress and Fiscal Second Quarter Financial Results
    Qualigen Therapeutics Issues CEO Letter to Stockholders, Reports on Significant Progress and Fiscal Second Quarter Financial Results PR Newswire
    05.11.20 - PR Newswire
    Qualigen Therapeutics Engages STA Pharmaceutical as GMP Manufacturer of AS1411 for Clinical Trials
    Qualigen Therapeutics Engages STA Pharmaceutical as GMP Manufacturer of AS1411 for Clinical Trials PR Newswire
    28.10.20 - PR Newswire
    Qualigen Therapeutics Receives Positive Pre-IND Response from FDA for the Clinical Development of AS1411 as a Treatment for COVID-19
    Qualigen Therapeutics Receives Positive Pre-IND Response from FDA for the Clinical Development of AS1411 as a Treatment for COVID-19 Plans to File IND Application and ...
    08.10.20 - PR Newswire
    Qualigen Therapeutics Enters into Commercialization Agreement for its FastPack® Diagnostic Products in China
    Qualigen Therapeutics Enters into Commercialization Agreement for its FastPack® Diagnostic Products in China Yi Xin Zhen Duan Jishu will develop new generations of FastPack-...
    04.05.20 - PR Newswire
    Thinking about buying stock in Stemline Therapeutics, KLX Energy, Trinity Biotech, Tilray, or Ritter Pharmaceuticals?
    Thinking about buying stock in Stemline Therapeutics, KLX Energy, Trinity Biotech, Tilray, or Ritter Pharmaceuticals? PR Newswire
    03.03.20 - PR Newswire
    Thinking about buying stock in Kohl's, Plug Power, Ritter Pharmaceuticals, AT&T, or Wells Fargo?
    Thinking about buying stock in Kohl's, Plug Power, Ritter Pharmaceuticals, AT&T, or Wells Fargo? PR Newswire

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »